165 related articles for article (PubMed ID: 20492573)
1. Single-dose pharmacokinetics of fentanyl buccal soluble film.
Vasisht N; Gever LN; Tagarro I; Finn AL
Pain Med; 2010 Jul; 11(7):1017-23. PubMed ID: 20492573
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
3. Formulation selection and pharmacokinetic comparison of fentanyl buccal soluble film with oral transmucosal fentanyl citrate: a randomized, open-label, single-dose, crossover study.
Vasisht N; Gever LN; Tagarro I; Finn AL
Clin Drug Investig; 2009; 29(10):647-54. PubMed ID: 19715381
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
[TBL] [Abstract][Full Text] [Related]
5. Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects : A Phase I, Open-Label, Three-Period, Crossover Study.
Finn AL; Vasisht N; Stark JG; Gever LN; Tagarro I
Clin Drug Investig; 2012 Jan; 32(1):63-71. PubMed ID: 27933600
[TBL] [Abstract][Full Text] [Related]
6. Dose proportionality of fentanyl buccal tablet in doses ranging from 600 to 1300 microg in healthy adult subjects: a randomized, open-label, four-period, crossover, single-centre study.
Darwish M; Kirby M; Robertson P; Tracewell W; Xie F
Clin Drug Investig; 2010; 30(6):365-73. PubMed ID: 20441245
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the single- and multiple-dose pharmacokinetics of fentanyl buccal soluble film in normal healthy volunteers.
Vasisht N; Gever LN; Tagarro I; Finn AL
J Clin Pharmacol; 2010 Jul; 50(7):785-91. PubMed ID: 20150521
[TBL] [Abstract][Full Text] [Related]
8. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.
Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
Clin Pharmacokinet; 2006; 45(8):843-50. PubMed ID: 16884321
[TBL] [Abstract][Full Text] [Related]
9. Intra- and interindividual variabilities in the pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a cross-study analysis.
Davies A; Finn A; Tagarro I
Clin Drug Investig; 2011; 31(5):317-24. PubMed ID: 21294598
[TBL] [Abstract][Full Text] [Related]
10. Fentanyl buccal tablet: in breakthrough pain in opioid-tolerant patients with cancer.
Blick SK; Wagstaff AJ
Drugs; 2006; 66(18):2387-93; discussion 2394-5. PubMed ID: 17181383
[TBL] [Abstract][Full Text] [Related]
11. Dose proportionality and pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-period, crossover study.
Finn AL; Vasisht N; Stark JG; Gever LN; Tagarro I
Clin Drug Investig; 2012 Jan; 32(1):63-71. PubMed ID: 22128878
[TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic study to compare two simultaneous 400 microg doses with a single 800 microg dose of oral transmucosal fentanyl citrate.
Lee M; Kern SE; Kisicki JC; Egan TD
J Pain Symptom Manage; 2003 Aug; 26(2):743-7. PubMed ID: 12906959
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Pharmacokinet; 2005; 44(12):1279-86. PubMed ID: 16372825
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalence following buccal and sublingual placement of fentanyl buccal tablet 400 microg in healthy subjects.
Darwish M; Kirby M; Jiang JG; Tracewell W; Robertson P
Clin Drug Investig; 2008; 28(1):1-7. PubMed ID: 18081355
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of buccal mucosal administration of fentanyl in a carboxymethylcellulose gel compared with IV administration in dogs.
Little AA; Krotscheck U; Boothe DM; Erb HN
Vet Ther; 2008; 9(3):201-11. PubMed ID: 19003781
[TBL] [Abstract][Full Text] [Related]
16. Multiple dose pharmacokinetics of oral transmucosal fentanyl citrate in healthy volunteers.
Egan TD; Sharma A; Ashburn MA; Kievit J; Pace NL; Streisand JB
Anesthesiology; 2000 Mar; 92(3):665-73. PubMed ID: 10719944
[TBL] [Abstract][Full Text] [Related]
17. The effect of dosing frequency on the pharmacokinetics of a fentanyl HCl patient-controlled transdermal system (PCTS).
Sathyan G; Zomorodi K; Gidwani S; Gupta S
Clin Pharmacokinet; 2005; 44 Suppl 1():17-24. PubMed ID: 16156112
[TBL] [Abstract][Full Text] [Related]
18. Oral transmucosal fentanyl citrate: overview of pharmacological and clinical characteristics.
Mystakidou K; Katsouda E; Parpa E; Vlahos L; Tsiatas ML
Drug Deliv; 2006; 13(4):269-76. PubMed ID: 16766468
[TBL] [Abstract][Full Text] [Related]
19. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
Parikh N; Goskonda V; Chavan A; Dillaha L
Clin Ther; 2013 Mar; 35(3):236-43. PubMed ID: 23497761
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the pharmacokinetics of the fentanyl HCl patient-controlled transdermal system (PCTS): effect of current magnitude and multiple-day dosing and comparison with IV fentanyl administration.
Sathyan G; Jaskowiak J; Evashenk M; Gupta S
Clin Pharmacokinet; 2005; 44 Suppl 1():7-15. PubMed ID: 16156111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]